|
1
|
Gemma M, Scola E, Baldoli C, Mucchetti M,
Pontesilli S, De Vitis A, Falini A and Beretta L: Auditory
functional magnetic resonance in awake (nonsedated) and
propofol-sedated children. Paediatr Anaesth. 26:521–530. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng Y, Bu J, Yu L, Chen J and Liu H:
Nobiletin improves propofol-induced neuroprotection via regulating
Akt/mTOR and TLR 4/NF-κB signaling in ischemic brain injury in
rats. Biomed Pharmacother. 91:494–503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Gong Y, Wang C, Wang X, Zhou Q,
Wang D, Guo L, Pi X, Zhang X, Luo S, et al: Online breath analysis
of propofol during anesthesia: Clinical application of membrane
inlet-ion mobility spectrometry. Acta Anaesthesiol Scand.
59:319–328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hua FZ, Ying J, Zhang J, Wang XF, Hu YH,
Liang YP, Liu Q and Xu GH: Naringenin pre-treatment inhibits
neuroapoptosis and ameliorates cognitive impairment in rats exposed
to isoflurane anesthesia by regulating the PI3/Akt/PTEN signalling
pathway and suppressing NF-κB-mediated inflammation. Int J Mol Med.
38:1271–1280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen X, Du YM, Xu F, Liu D and Wang YL:
Propofol prevents hippocampal neuronal loss and memory impairment
in cerebral ischemia injury through promoting PTEN degradation. J
Mol Neurosci. 60:63–70. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Wang W, Zhang J, Li S, Zhao Y, Tan
L and Luo A: Involvement of caspase-3/PTEN signaling pathway in
isoflurane-induced decrease of self-renewal capacity of hippocampal
neural precursor cells. Brain Res. 1625:275–286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang LY, Tang ZJ and Han YZ:
Neuroprotective effects of caffeic acid phenethyl ester against
sevoflurane induced neuronal degeneration in the hippocampus of
neonatal rats involve MAPK and PI3K/Akt signaling pathways. Mol Med
Rep. 14:3403–3412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma J, Xiao W, Wang J, Wu J, Ren J, Hou J,
Gu J, Fan K and Yu B: Propofol inhibits NLRP3 inflammasome and
attenuates blast-induced traumatic brain injury in rats.
Inflammation. 39:2094–2103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao R, Gan M and Jiang T: Wogonoside
exerts growth-suppressive effects against T acute lymphoblastic
leukemia through the STAT3 pathway. Hum Exp Toxicol. 36:1169–1176.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karnati HK, Panigrahi MK, Gutti RK, Greig
NH and Tamargo IA: miRNAs: Key players in neurodegenerative
disorders and epilepsy. J Alzheimers Dis. 48:563–580. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu EY, Cali CP and Lee EB: RNA metabolism
in neurodegenerative disease. Dis Model Mech. 10:509–518. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Wu C, Han B, Xu F, Mao M, Guo X
and Wang J: Dexmedetomidine attenuates repeated propofol
exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling
disruption, and juvenile cognitive deficits in neonatal rats. Mol
Med Rep. 14:769–775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen B, Deng X, Wang B and Liu H:
Persistent neuronal apoptosis and synaptic loss induced by multiple
but not single exposure of propofol contribute to long-term
cognitive dysfunction in neonatal rats. J Toxicol Sci. 41:627–636.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JH, Kim BK, Kim DW, Shin HY, Yu SB,
Kim DS, Ryu SJ, Kim KH, Jang HK and Kim JD: Effect of propofol on
microRNA expression profile in adipocyte-derived adult stem cells.
Chonnam Med J. 50:86–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eberl S, Preckel B, Bergman JJ, van Dieren
S and Hollmann MW: Satisfaction and safety using dexmedetomidine or
propofol sedation during endoscopic oesophageal procedures: A
randomised controlled trial. Eur J Anaesthesiol. 33:631–637. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang T, Guo Q, Li L, Cheng Y, Ren C and
Zhang G: MicroRNA-433 inhibits migration and invasion of ovarian
cancer cells via targeting Notch1. Neoplasma. 63:696–704. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang J, Xia Y, Xu Z and Deng X: Propofol
suppressed hypoxia/reoxygenation-induced apoptosis in HBVSMC by
regulation of the expression of Bcl-2, bax, caspase3, kir6.1, and
p-JNK. Oxid Med Cell Longev. 2016:15187382016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z, Tsuchiya H, Zhang Y, Hartnett ME
and Wang L: MicroRNA-433 inhibits liver cancer cell migration by
repressing the protein expression and function of cAMP response
element-binding protein. J Biol Chem. 288:28893–28899. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
An K, Shu H, Huang W, Huang X, Xu M, Yang
L, Xu K and Wang C: Effects of propofol on pulmonary inflammatory
response and dysfunction induced by cardiopulmonary bypass.
Anaesthesia. 63:1187–1192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou CH, Zhu YZ, Zhao PP, Xu CM, Zhang MX,
Huang H, Li J, Liu L and Wu YQ: Propofol inhibits
lipopolysaccharide-induced inflammatory responses in spinal
astrocytes via the toll-like receptor 4/MyD88-dependent nuclear
factor-κB, extracellular signal-regulated protein kinases1/2, and
p38 mitogen-activated protein kinase pathways. Anesth Analg.
120:1361–1368. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang YJ, Zhang ZF, Fan SH, Zhuang J, Shan
Q, Han XR, Wen X, Li MQ, Hu B, Sun CH, et al: MicroRNA-433 inhibits
oral squamous cell carcinoma cells by targeting FAK. Oncotarget.
8:100227–100241. 2017.PubMed/NCBI
|
|
23
|
Li M, Yang HM, Luo DX, Chen JZ and Shi HJ:
Multi-dimensional analysis on parkinson's disease questionnaire-39
in parkinson's patients treated with bushen huoxue granule: A
multicenter, randomized, double-blinded and placebo controlled
trial. Complement Ther Med. 29:116–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leavy B, Kwak L, Hagstromer M and Franzen
E: Evaluation and implementation of highly challenging balance
training in clinical practice for people with Parkinson's disease:
Protocol for the hibalance effectiveness-implementation trial. BMC
Neurol. 17:272017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van de Weijer SC, Duits AA, Bloem BR,
Kessels RP, Jansen JF, Köhler S, Tissingh G and Kuijf ML: The
Parkin'Play study: Protocol of a phase II randomized controlled
trial to assess the effects of a health game on cognition in
Parkinson's disease. BMC Neurol. 16:2092016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xue J, Chen LZ, Li ZZ, Hu YY, Yan SP and
Liu LY: MicroRNA-433 inhibits cell proliferation in hepatocellular
carcinoma by targeting p21 activated kinase (PAK4). Mol Cell
Biochem. 399:77–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
